Rafael Santamaría

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

Manuel Gorostidi, Rafael Santamaría, Roberto Alcázar Arroyo et al. · PubMed · 2014 · 88 citations

Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors

Manuel Gorostidi, Mercedes Sánchez-Martínez, Luís M. Ruilope et al. · Nefrología (English Edition) · 2018 · 60 citations · Full text

Cinacalcet Reduces the Set Point of the PTH-Calcium Curve

Casimiro Valle, Mariano Rodríguez, Rafael Santamaría et al. · Journal of the American Society of Nephrology · 2008 · 59 citations · Full text